Immunostimulatory oligonucleotide multimers
US7427405B2 · kind B2 · utility
28Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2005 |
| Grant date | Sep 23, 2008 |
| Priority date | — |
| Expiry date | Jan 26, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides an immunostimulatory nucleic acid. In certain embodiments according to this aspect of the invention, the sequence of the immunostimulatory oligonucleotide and/or immunomer is at least partially self-complementary.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.